Compare CLOV & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLOV | RAPP |
|---|---|---|
| Founded | 2014 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | N/A | 2024 |
| Metric | CLOV | RAPP |
|---|---|---|
| Price | $2.58 | $29.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $4.23 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 5.4M | 377.9K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,773,564,000.00 | N/A |
| Revenue This Year | $41.68 | N/A |
| Revenue Next Year | $37.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.15 | N/A |
| 52 Week Low | $2.12 | $6.43 |
| 52 Week High | $4.87 | $42.27 |
| Indicator | CLOV | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 62.48 |
| Support Level | $2.41 | $26.92 |
| Resistance Level | $2.72 | $30.44 |
| Average True Range (ATR) | 0.12 | 1.80 |
| MACD | 0.04 | 0.20 |
| Stochastic Oscillator | 74.98 | 90.28 |
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.